Repeat kidney biopsy unmasks the transition from active inflammation to irreversible damage in lupus nephritis: longitudinal outcomes from a single-center cohort in Egypt.
文献摘要
Background Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus, and repeat kidney biopsy has a potential value in monitoring disease progression and impact on treatment adjustments. Methods We retrospectively analyzed 81 Egyptian LN patients who underwent two kidney biopsies at the Urology and Nephrology Center, Mansoura University, between January 2011 and April 2024. Indications included persistent proteinuria, active urinary sediment, or unexplained renal impairment. Demographic, clinical, laboratory, histological, and treatment data were collected. Pathology was assessed using the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification, activity and chronicity indices, and outcomes were analyzed by Cox regression. Results At repeat biopsy, pathological transitions occurred in 48%. The transition toward more severe disease categories was frequent and included: Class I/II to III/IV: 7 of 10 patients, Class III to IV: 6 of 11 patients, Class III/IV + V to IV: all 3 patients, Class IV to VI: 5 of 49 patients, Class V to III/IV/VI: 6 of 8 patients. The activity index decreased (median 12→7, P Conclusion Repeat biopsy is of pivotal importance in LN, unmasking critical histological transitions and shifts towards chronicity that can guide essential therapy changes and improve prognostication beyond clinical assessment alone.